US › Healthcare

enVVeno Medical Corp (NVNO)

US · Healthcare · Medical Devices

$11.15+4.21%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-3.6M
Profit YoY
+46.2%
EPS
$-5.37
EPS estimate
$-4.69

EPS came in at -5.37 against a street estimate of -4.69 — a miss of 14.5%.

Key statistics

Market cap
$7.1M
Forward P/E
0.0
P/B
0.34
Book value
$36.20
EPS (TTM)
$-24.97
52-week high
$179.55
52-week low
$8.67
50-day MA
$10.66
200-day MA
$12.66
Beta
1.09

Analyst view

Analysts rate enVVeno Medical Corp a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $30.00.

Shareholding

Insiders
13.38%
Institutions
25.61%

Largest institutional holders

FundStake
Kingdon Capital Management LLC5.42%
CM Management, LLC5.35%
Geode Capital Management, LLC1.57%
Vanguard Capital Management, LLC0.94%
JPMorgan Chase & Co0.78%
Vanguard Fiduciary Trust Co0.33%
BlackRock Inc0.28%
Westside Investment Management, Inc.0.24%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for enVVeno Medical Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.